​Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

​This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.

Principal Investigator: Dr. Eric Knoche
Study Coordinator: Linda Schimmoeller

This study is now closed. 

This study was funded by the Foundation through Pfizer